ACAD vs RLAY
ACADIA Pharmaceuticals Inc · Relay Therapeutics Inc
Relative return (rebased to 100)
Key stats
| Metric | ACAD | RLAY |
|---|---|---|
| Price | $25.39 | $18.64 |
| Market Cap | $4.35B | $3.57B |
| P/E | 11.12 | — |
| P/B | 3.48 | 5.56 |
| P/S | 4.06 | 232.57 |
| ROE | 31.3% | -43.1% |
| Net Margin | 36.5% | -1800.6% |
| Gross Margin | 63.9% | — |
| Revenue Growth | 11.9% | 53.4% |
| Dividend Yield | — | — |
| EPS | $2.28 | -$1.44 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.